UPFIELD
Today, Upfield, a leading producer of plant-based products, announced partnership with Starling to ensure their ongoing support for Upfield’s vision for a “Better Plant Based Future” drives innovation in ingredient sourcing that protect the world’s precious ecosystems and preserves our planet for future generations.
In response to climate change and the devastating impact of deforestation, Upfield is committed to responsibly sourcing ingredients, paying particular attention to palm oil, soybean oil and paper, vetting partners to verify compliance with Upfield policies and maintaining transparency by publishing details of product ingredient sources. Upfield is committed to driving industry transformation and ensuring that deforestation doesn’t take place within their supply chain.
At the beginning of the year Upfield committed to source 100% of its palm oil from physically certified, sustainable sources by December 2019 and today can announce that they have achieved this target. All the palm oil Upfield directly purchases is now 100% physically certified to RPSO standards.
“This is an important step in delivering on our palm oil policy commitments,” said Sally Smith, Head of Sustainability, “ensuring we source our directly purchased ingredients sustainably and responsibly, particularly where there is a risk of deforestation, is a priority for Upfield. There continues to be more to do.”
Upfield sources both mass balance and segregated certified palm oil and will continue to work with suppliers and farmers to increase the proportion of segregated palm oil used in its products.
Upfield also shares the concerns about the production of soy products and is working toward full transparency, collaborating with community leaders and expert third parties. Ninety-five percent of Upfield’s soybean oil is grown in the United States and Canada and is compliant with local environmental regulations. The remaining five percent is sourced from Europe and Brazil, in compliance with the Amazon Basin Soy Moratorium Zone.
Additionally, today Upfield is announcing their partnership with Starling to use their innovative satellite monitoring technology platform to further support efforts in eradicating deforestation from their supply chain. Starling, created by Airbus and Earthworm, uses high resolution imagery and radar data to monitor land cover changes.
By mapping the location of mills within the supply chain, Upfield will be able to see where deforestation continues to occur. Upfield will be piloting the system initially in Indonesia where 50% of its palm oil and 70% of the high risks mills in their supply chain are located. In 2020 they will extend its use to cover their global palm oil supply chain. And finally, they will use the information to verify compliance and to help address deforestation risks with their suppliers.
Transparency is essential in ensuring sustainable supply chains and Upfield is committed to monitor, verify and act on the insights that Starling will provide. “Only by being equipped with information about deforestation and supply chains are companies able to take proactive action to tackle deforestation and evidence progress. That is what will eventually allow consumers and investors to really see which companies are truly walking the talk,” said Bastien Sachet, CEO of Earthworm Foundation.
ABOUT UPFIELD
At Upfield, we make people healthier and happier with great tasting, plant-based nutrition products that are better for the planet. As a global plant-based company, Upfield is the #1 producer of plant-based spreads with more than 60 brands, including iconic brands Flora, Rama, Blue Band, Proactive, Becel, I Can’t Believe It’s Not Butter and Country Crock. With headquarters in Amsterdam, we sell our products in over 95 countries and have 17 manufacturing sites throughout the world. The company employs over 3500 Associates. Since 1871, we have been the authority in the spreads category which gives us unmatched experience, know-how and inspiration. We are focused on leading in this new era focused on delivering healthier products that are great tasting and have superior quality and helps us deliver on our mission to create “Better Plant-based Future.” For more information, please visit our website at www.Upfield.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190918005693/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom